Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of 12 citing Haupt: Effect of glimepiride on insulin-stimulated glycogen synthesis in cultured human skeletal.... (0.09 sec) 

Characteristics and time course of severe glimepiride-versus glibenclamide- …


A Holstein, A Plaschke, C Hammer, EH Egberts - European journal of clinical …, 2003 - Springer
Abstract Objective: To compare the clinical character- istics and time course of severe hypoglycaemia
(SH) on glimepiride and the reference drug glibenclamide. Methods: SH was defined as a symptomatic
event requiring administration of iv glucose or of glucagon. Four hundred doctors working ...
Cited by 31 - Related articles - BL Direct - All 4 versions

[PDF] Use of glimepiride and insulin sensitizers in the treatment of type 2 diabetes—a …


A Ramachandran, C Snehalatha, J Salini, V Vijay - JAPI, 2004 - japi.org
Aim : Short-term efficacy of glimepiride, metformin and pioglitazone in newly diagnosed type
2 diabetes was compared with a group treated with diet and exercise. Effects on insulin secretion
and sensitivity were also assessed. Methods : New type 2 diabetic subjects, aged 30-60 ...
Cited by 15 - Related articles - View as HTML - All 4 versions

Glimepiride enhances intrinsic peroxisome proliferator-activated receptor-γ activity …


K Inukai, M Watanabe, Y Nakashima, N Takata, A … - … and Biophysical Research …, 2005 - Elsevier
Glimepiride, a third-generation sulfonylurea (SU), exerts its effects mainly by stimulating insulin
secretion but has also been shown to have pleiotropic effects. Recent clinical studies showed
glimepiride to enhance insulin sensitivity. In the present study, to clarify the mechanism by ...
Cited by 15 - Related articles - All 3 versions

Efficacy of glimepiride in Japanese type 2 diabetic subjects


K Inukai, M Watanabe, Y Nakashima, T Sawa, N … - Diabetes research and …, 2005 - Elsevier
We investigated the efficacy of glimepiride, a third-generation sulfonylurea (SU), in Japanese
type 2 diabetic patients in whom glycemic control had been inadequate with a conventional
SU, gliclazide or glibenclamide. A total of 172 Japanese type 2 diabetic patients (HbA1C ...
Cited by 8 - Related articles - All 10 versions

Glimepiride activates eNOS with a mechanism Akt but not caveolin-1 dependent


B Salani, S Repetto, R Cordera, D Maggi - Biochemical and Biophysical …, 2005 - Elsevier
Insulin stimulates caveolin-1 and eNOS phosphorylation. The sulfonylurea glimepiride mimics
several insulin actions by mechanisms that are poorly understood. Glimepiride induces
caveolin-1 phosphorylation and activates PI3K and Akt in rat adipocytes. In this paper, we ...
Cited by 7 - Related articles - All 4 versions

Efficacy of glimepiride in type 2 diabetic patients treated with glibenclamide


T Hamaguchi, T Hirose, H Asakawa, Y Itoh, K … - Diabetes research and …, 2004 - Elsevier
Multicentric study was conducted to evaluate the efficacy of glimepiride in the oral hypoglycemic
agents therapy of type 2 diabetic patients treated with glibenclamide so far, and to claim an adequate
use of this new generation sulfonylurea. In 66 diabetic outpatients, glibenclamide was ...
Cited by 2 - Related articles - All 3 versions

The Mode of Action of the Antidiabetic Drug Glimepiride-Beyond Insulin Secretion


G Muller - Current Medicinal Chemistry-Immunology, Endocrine & …, 2005 - ingentaconnect.com
Abstract: During the past 10 years a multitude of clinical and observational studies have confirmed
the efficacy of the antidiabetic drug, glimepiride, in lowering fasting and postprandial blood glucose
in lean and obese type 2 diabetic pa- tients even after a single administration per day, ...
Related articles - BL Direct

[PDF] INSULIN GLARGINE COMBINED WITH ORAL AGENT IN T2DM (CLINICAL USES …


A Tjokroprawiro - Folia Medica Indonesiana, 2005 - journal.unair.ac.id
A map of oral agents for diabetes (OADS), either at present or in the future should be well
recognized. Four of such OADS (glimepiride, glinides, gliclazide, metformin) have claimed showing
atheroprotective properties beyond its hypoglycemic or anti- hypoglycemic effects. On the ...
Related articles - View as HTML - All 2 versions

[PDF] RECENT ADVANCES IN DIABETES TREATMENT OPTIONS ( …


A Tjokroprawiro - Channels - journal.unair.ac.id
In clinical practice, Oral Hypoglycemic Agents (OHAS) and Oral Antihyperglicemic Agents
(OAAS) can be categorized into 3 classes: 1. Insulin Secretagogues (Sulphonylureas = SUS:
Glimepiride, Glipizide XL, Glibenclamide, Gliclazide, Gliquidone, etc, and Non–SUS: ...
Related articles - View as HTML - All 2 versions

[PDF] CONDUITE À TENIR/MANAGEMENT UPDATE


D SUCRÉ, ADELAPEN CHARGE, ETO … - lebanesemedicaljournal.org
Le diabète sucré est un syndrome métabolique carac- térisé essentiellement par une hyperglycémie
résultant d'un déficit absolu ou relatif de l'insulino-sécrétion et/ou d'anomalies d'action de
l'insuline. L'hyperglycémie chronique s'accompagne de lésions et de dysfonctionnement ...
Related articles


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google